Preemptive PGx Testing Gaining New Momentum
From - Diagnostic Testing & Emerging Technologies
The application of pharmacogenomics (PGx) into routine, clinical care remains very limited, despite its potential to improve drug and…
From - Diagnostic Testing & Emerging Technologies
The application of pharmacogenomics (PGx) into routine, clinical care remains very limited, despite its potential to improve drug and…
...
From - Laboratory Industry Report
Five major players in genetic testing have joined forces to promote cell-free DNA (cfDNA)-based noninvasive prenatal testing (NIPT). A newly formed organization…
...
From - Diagnostic Testing & Emerging Technologies
A constant refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of …